Immediate Impact

50 standout
Sub-graph 1 of 23

Citing Papers

Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Effects of nanoparticle size, shape, and zeta potential on drug delivery
2024 Standout
2 intermediate papers

Works of Saurabh Ray being referenced

Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population.
2014
Comparative analysis of survival, treatment, cost and resource use among patients newly diagnosed with brain metastasis by initial primary cancer
2013

Author Peers

Author Last Decade Papers Cites
Saurabh Ray 149 137 112 62 651
Guillermo Lorenzo 13 35 95 27 751
Ovidiu Daescu 118 44 96 50 624
Xiaoying Tian 5 14 37 56 749
Tsutomu Endo 28 9 41 87 746
Francisco J. López 12 57 17 73 767
Wenli Zhou 17 154 26 35 679
Annalisa Barla 2 44 29 63 790
Lanju Zhang 177 21 46 846
Emese Balogh 8 20 28 35 739
Umberto Nanni 43 168 15 36 606

All Works

Loading papers...

Rankless by CCL
2026